BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32017698)

  • 1.
    Pujadas E; Chen L; Weingart JD; Orr B; Ozer BH; Holdhoff M; Rodriguez FJ
    Clin Neuropathol; 2020; 39(4):179-187. PubMed ID: 32017698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid spontaneous malignant progression of supratentorial tanycytic ependymoma with sarcomatous features - "Ependymosarcoma".
    Vajtai I; Kuhlen D; Kappeler A; Mariani L; Zimmermann A; Paulus W
    Pathol Res Pract; 2010 Jul; 206(7):493-8. PubMed ID: 19853384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of t(1;19)(q12;p13) and ploidy changes in an ependymosarcoma: a cytogenetic evaluation.
    Tabbarah AZ; Carlson AW; Oviedo A; Ketterling RP; Rodriguez FJ
    Clin Neuropathol; 2012; 31(3):142-5. PubMed ID: 22551918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic study.
    Rodriguez FJ; Scheithauer BW; Perry A; Oliveira AM; Jenkins RB; Oviedo A; Mork SJ; Palmer CA; Burger PC
    Am J Surg Pathol; 2008 May; 32(5):699-709. PubMed ID: 18347506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliosarcoma arising from an anaplastic ependymoma: a case report of a rare entity.
    Behling E; Birbe R; Veznadaroglu E; Andrews DW; Flanders A; Kenyon LC
    Hum Pathol; 2004 Apr; 35(4):512-6. PubMed ID: 15116335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple chromosomal monosomies are characteristic of giant cell ependymoma.
    Dahlback HS; Brandal P; Krossnes BK; Fric R; Meling TR; Meza-Zepeda LA; Danielsen HE; Heim S
    Hum Pathol; 2011 Dec; 42(12):2042-6. PubMed ID: 21683982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing.
    Butt E; Alyami S; Nageeti T; Saeed M; AlQuthami K; Bouazzaoui A; Athar M; Abduljaleel Z; Al-Allaf F; Taher M
    F1000Res; 2019; 8():613. PubMed ID: 32612806
    [No Abstract]   [Full Text] [Related]  

  • 8. Anaplastic ependymoma with ependymoblastic multilayered rosettes.
    Nobusawa S; Suzuki A; Nagaishi M; Isoda K; Ikota H; Yokoo H; Hirato J; Nakazato Y
    Hum Pathol; 2013 Nov; 44(11):2597-602. PubMed ID: 23791209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
    Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
    Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant transformation of supratentorial clear cell ependymoma.
    Kurimoto M; Nagai S; Hamada H; Tsuboi Y; Hayashi N; Kubota T; Endo S
    Neuropathology; 2009 Jun; 29(3):299-302. PubMed ID: 18647267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic ependymoma simulating glioblastoma in the cerebrum of an adult.
    Shintaku M; Hashimoto K
    Brain Tumor Pathol; 2012 Jan; 29(1):31-6. PubMed ID: 21833575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncocytic ependymoma: a new morphological variant of high-grade ependymal neoplasm composed of mitochondrion-rich epithelioid cells.
    Vajtai I; von Gunten M; Fung C; Brekenfeld C; Kappeler A; Reinert MM
    Pathol Res Pract; 2011 Jan; 207(1):49-54. PubMed ID: 20566250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.
    Cachia D; Wani K; Penas-Prado M; Olar A; McCutcheon IE; Benjamin RS; Armstrong TS; Gilbert MR; Aldape KD
    Brain Tumor Pathol; 2015 Apr; 32(2):105-11. PubMed ID: 25388523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of histopathological ependymoma variants.
    Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
    Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYCN amplification drives an aggressive form of spinal ependymoma.
    Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
    Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent anaplastic ependymoma with an abnormal karyotype and c-myc proto-oncogene overexpression.
    Debiec-Rychter M; Lasota J; Alwasiak J; Liberski PP
    Acta Neuropathol; 1995; 89(3):270-4. PubMed ID: 7538722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ependymoma relapse goes along with a relatively stable epigenome, but a severely altered tumor morphology.
    Yang D; Holsten T; Börnigen D; Frank S; Mawrin C; Glatzel M; Schüller U
    Brain Pathol; 2021 Jan; 31(1):33-44. PubMed ID: 32633004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leser-Trélat sign with anaplastic ependymoma--an autopsy case.
    Hamada Y; Iwaki T; Muratani H; Imayama S; Fukui M; Tateishi J
    Acta Neuropathol; 1997 Jan; 93(1):97-100. PubMed ID: 9006663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
    Olsen TK; Panagopoulos I; Meling TR; Micci F; Gorunova L; Thorsen J; Due-Tønnessen B; Scheie D; Lund-Iversen M; Krossnes B; Saxhaug C; Heim S; Brandal P
    Neuro Oncol; 2015 Oct; 17(10):1365-73. PubMed ID: 25795305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical status epilepticus due to anaplastic cortical ependymoma.
    Ohla V; Smith K; Drees C
    Clin Neurol Neurosurg; 2012 Jul; 114(6):710-2. PubMed ID: 22209145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.